Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2002 2
2003 3
2004 1
2005 7
2006 4
2007 4
2008 5
2009 7
2010 4
2011 3
2012 10
2013 9
2014 9
2015 13
2016 8
2017 12
2018 9
2019 7
2020 6
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 29848725

118 results
Results by year
Filters applied: . Clear all
Page 1
Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
Sierra Díaz E, Sánchez Corona J, Rosales Gómez RC, Gutierrez Rubio SA, Vázquez Camacho JG, Solano Moreno H, Morán Moguel MC. Sierra Díaz E, et al. J Renin Angiotensin Aldosterone Syst. 2009 Dec;10(4):241-6. doi: 10.1177/1470320309352800. J Renin Angiotensin Aldosterone Syst. 2009. PMID: 20026870 Free article.
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
Ma Z, Tsuchiya N, Yuasa T, Inoue T, Kumazawa T, Narita S, Horikawa Y, Tsuruta H, Obara T, Saito M, Satoh S, Ogawa O, Habuchi T. Ma Z, et al. Int J Cancer. 2008 Dec 1;123(11):2574-9. doi: 10.1002/ijc.23578. Int J Cancer. 2008. PMID: 18756523 Free article.
118 results